A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT04627961
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Nasopharyngeal Carcinoma
Recurrent Nasopharyngeal Carcinoma
Interventions
DRUG:
TAS-102
Sponsor
National University Hospital, Singapore